ChartRow logo
AMPH
$25.94-0.77%
as of close, Oct 20, 2026
☾ AH $25.94 -0.77%
PeersMRNALLYMDTUNHJNJTMO
Share this page

AMPH financial statements

The full income statement, balance sheet, and cash-flow statement for Amphastar Pharmaceuticals Inc. (AMPH), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 48.7M2024-09 48.1M2024-12 47.7M2025-03 47.1M2025-06 46.5M2025-09 46.0M2025-12 45.4M2026-03 44.1M2026-06 42.5M-12.6% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue720M-1.7%732M+13.6%644M+29.1%499M+14.0%438M+25.1%
356M-4.8%374M+6.5%351M+41.1%249M+24.6%200M+39.3%
Cost of revenue364M+1.6%358M+22.1%293M+17.3%250M+5.1%238M+15.3%
216M+28.0%168M+9.3%154M+9.0%141M+8.9%130M-1.9%
Research & development85.8M+16.1%73.9M+0.2%73.7M-1.4%74.8M+22.7%60.9M-9.4%
Selling, general & administrative85.9M+51.5%56.7M+10.1%51.5M+14.4%45.1M-12.4%51.4M+2.1%
General & administrative85.9M+51.5%56.7M+10.1%51.5M+14.4%45.1M-12.4%51.4M+2.1%
Selling & marketing43.9M+16.1%37.8M+31.0%28.9M+34.0%21.5M+23.1%17.5M+18.3%
Amortization of intangibles25.0M+1.3%24.7M+92.7%12.8M+1244.9%954K-10.9%1.07M+3.4%
Operating income140M-31.7%205M+4.3%197M+83.2%107M+53.8%69.9M+538.0%
Interest expense25.5M-16.0%30.3M+11.7%27.2M+1371.2%1.85M+108.6%885K+136.6%
Interest & investment income8.68M-18.2%10.6M+94.4%5.46M+313.2%1.32M+119.8%601K-6.4%
Other non-operating income23.0K-99.4%4.08M+203.7%-3.93M-143.3%9.07M-37.6%14.5M+320.7%
Equity-method income—-573K+71.1%-1.98M-68.3%-1.18M-465.9%-208K
Pre-tax income124M-34.9%190M+10.7%171M+47.7%116M+37.9%84.1M+1714.5%
Income tax25.5M-14.0%29.7M-6.8%31.8M+35.6%23.5M+13.8%20.6M+482.8%
98.1M-38.5%160M+16.0%138M+50.5%91.4M+47.1%62.1M+4327.4%
Net income to non-controlling interest
————1.19M+487.3%
$2.03-33.7%$3.06+17.7%$2.60+49.4%$1.74+39.2%$1.25+4066.7%
EPS (basic)$2.10-36.2%$3.29+15.4%$2.85+51.6%$1.88+44.6%$1.30+4233.3%
Weighted-avg shares (basic)46.7M-3.5%48.4M+0.3%48.3M-0.6%48.6M+1.6%47.8M+1.6%
Weighted-avg shares (diluted)48.2M-7.4%52.1M-1.8%53.0M+1.1%52.4M+5.3%49.8M+1.3%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
636M+19.1%534M+9.1%490M+29.4%378M+18.9%318M+13.7%
Cash & equivalents170M+12.2%152M+5.1%144M-7.6%156M+23.5%126M+36.4%
Short-term investments113M+60.8%70.0M-37.8%113M+472.2%19.7M+90.5%10.3M-20.5%
Accounts receivable144M+5.3%136M+18.6%115M+29.4%88.8M+12.7%78.8M+19.4%
Inventory177M+15.1%154M+45.3%106M+2.2%104M+11.6%92.8M-4.2%
Prepaid expenses13.2M-27.8%18.2M+101.1%9.06M+19.8%7.56M+4.0%7.27M+7.3%
1.63B+3.3%1.58B+4.3%1.51B+103.9%742M+10.5%672M+6.4%
Property, plant & equipment311M+4.4%297M+5.2%283M+18.7%238M-2.4%244M-6.1%
Operating lease right-of-use42.9M-8.5%46.9M+45.0%32.3M+26.5%25.6M-5.0%26.9M+34.2%
Goodwill3.40M+11.6%3.05M-5.2%3.22M+2.9%3.13M-5.6%3.31M-15.9%
Intangible assets533M-4.5%558M-3.9%581M+11641.5%4.95M-21.9%6.33M-15.0%
Long-term investments—11.0M-25.1%14.7M——
Deferred tax assets42.5M-40.3%71.1M+33.6%53.3M+38.2%38.5M+72.0%22.4M-10.3%
Other non-current assets31.1M+19.8%26.0M+0.3%25.9M+24.2%20.9M+25.1%16.7M+217.4%
158M-9.0%174M-22.9%225M+137.6%94.9M-8.6%104M-7.5%
Accounts payable32.6M+6.8%30.5M+20.0%25.4M+24.1%20.5M-7.7%22.2M-8.8%
Accrued liabilities116M-8.5%127M+86.3%67.9M+6.6%63.7M-5.3%67.3M-5.4%
Short-term & current debt1.64M+601.3%234K-46.3%436K-85.7%3.05M+38.3%2.20M-82.0%
Current lease liability7.93M+16.5%6.80M+74.2%3.91M+30.1%3.00M+0.7%2.98M-11.2%
840M-0.6%845M-3.2%873M+309.5%213M-5.6%226M+23.8%
Long-term debt620M+1.0%614M+1.7%603M+687.0%76.6M-2.0%78.2M+70.3%
Non-current lease liability37.7M-10.0%41.9M+40.9%29.7M+25.4%23.7M-4.1%24.7M+41.5%
Operating lease liability (total)45.6M-6.3%48.7M+44.8%33.6M+26.0%26.7M-3.6%27.7M+33.0%
Finance lease liability264K-38.9%432K-29.9%616K-22.0%790K+98.5%398K-34.8%
Deferred tax liabilities———144K-73.0%534K-27.9%
Other non-current liabilities30.0M+43.1%20.9M-7.8%22.7M+56.0%14.6M-7.0%15.7M+18.5%
789M+7.7%732M+14.5%639M+21.0%529M+18.7%446M+10.7%
Common stock6.00K+0.0%6.00K+0.0%6.00K+0.0%6.00K+0.0%6.00K+20.0%
Additional paid-in capital535M+5.9%505M+4.0%486M+6.8%455M+7.7%422M+3.0%
Retained earnings667M+17.2%569M+39.0%409M+50.6%272M+50.7%180M+53.1%
Treasury stock408M+22.7%333M+34.5%247M+30.6%190M+25.9%150M+23.5%
Accumulated other comprehensive income-5.31M+42.1%-9.18M-8.3%-8.48M+1.7%-8.62M-27.5%-6.76M-81.8%
Total equity incl. non-controlling789M+7.7%732M+14.5%639M+21.0%529M+18.7%446M-0.7%
Total liabilities & equity1.63B+3.3%1.58B+4.3%1.51B+103.9%742M+10.5%672M+6.4%
Common shares issued61.8M+1.5%60.8M+2.5%59.4M+2.2%58.1M+3.0%56.4M+3.1%
Common shares outstanding45.6M-4.1%47.6M-0.9%48.1M-0.1%48.1M+0.8%47.7M+0.5%
Shares outstanding (cover)45.4M-4.8%47.7M-0.9%48.1M+0.4%47.9M-0.5%48.1M+1.5%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
156M-26.8%213M+16.3%184M+105.8%89.2M-9.0%98.0M+71.1%
Depreciation & amortization56.7M+7.0%53.0M+105.8%25.7M+104.3%12.6M+23.2%10.2M+13.2%
Intangible amortization25.0M+1.3%24.7M+92.7%12.8M+1244.9%954K-10.9%1.07M+3.4%
Share-based compensation27.3M+11.9%24.4M+20.4%20.2M+13.3%17.9M-4.4%18.7M-8.8%
Deferred income taxes28.7M+267.2%-17.1M-23.7%-13.9M+12.7%-15.9M-531.0%3.68M+301.7%
Change in receivables6.37M-70.6%21.7M-16.9%26.1M+157.5%10.1M-32.1%14.9M-26.0%
Change in inventory21.1M-56.8%48.8M+2730.5%1.72M-85.3%11.7M+1033.7%-1.26M+91.8%
-70.3M+43.7%-125M+80.8%-649M-1880.4%-32.8M-14.3%-28.7M+21.3%
Capital expenditure34.9M-15.0%41.0M+7.5%38.2M+58.8%24.0M-12.5%27.5M-18.9%
Free cash flow121M-29.7%172M+18.6%145M+123.1%65.1M-7.6%70.5M+201.3%
Acquisitions0.000.000.000.000.00
Proceeds from sale of PP&E
———421K—
-67.4M+16.7%-81.0M-117.8%454M+1817.5%-26.4M+28.6%-37.0M-1548.2%
Long-term debt issued0.000.00-100.0%845M0.00-100.0%70.0M+1014.1%
Long-term debt repaid223K-97.3%8.26M-97.4%319M+17792.1%1.78M-95.2%36.7M+337.3%
Common stock issued0.000.000.000.000.00
Common stock repurchased75.6M-11.6%85.5M+47.0%58.1M+45.7%39.9M+38.2%28.9M+18.2%
Dividends paid0.000.000.000.000.00
FX effect on cash210K+210.5%-190K+32.6%-282K-28.2%-220K+1.3%-223K-163.4%
Net change in cash18.6M+153.9%7.31M+162.0%-11.8M-139.7%29.7M-7.3%32.1M+69.2%
Interest paid23.2M-13.4%26.8M+52.6%17.6M+481.3%3.02M+43.3%2.11M-4.1%
Income taxes paid22.7M-43.4%40.1M-18.2%49.0M+10.3%44.4M+448.9%8.10M+137.3%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap1.22B-31.3%1.77B-40.3%2.96B+118.8%1.35B+20.8%1.12B+17.6%
P/E12.4×+11.7%11.1×-49.4%21.9×+24.9%17.5×-2.9%18.1×-97.3%
P/S1.7×-30.2%2.4×-50.9%4.9×+76.4%2.8×+9.0%2.6×-6.1%
P/B1.5×-36.2%2.4×-51.5%5.0×+85.7%2.7×+6.5%2.5×+6.2%
P/FCF10.0×-2.4%10.3×-51.6%21.2×+40.5%15.1×-5.1%15.9×-61.0%
Earnings yield8.1%-10.5%9.0%+97.5%4.6%-19.9%5.7%+3.0%5.5%+3666.2%
FCF yield10.0%+2.4%9.7%+106.4%4.7%-28.8%6.6%+5.4%6.3%+156.3%
Source filing10-K10-K10-K10-K10-K

About this data

Source: AMPH’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all AMPH filings on SEC EDGAR → Not investment advice.